Brazilian Journal of Health Review · Sep 24, 2026
SKIN CHANGES DURING MENOPAUSE: THE ROLE OF ESTROGEN DEFICIENCY IN THE SKIN, HAIR, AND GENITAL MUCOSA
By Melo GC, WIEDERMANN CT, Santos DEAV et al.
Characterized by the permanent cessation of menstrual cycles due to reduced ovarian follicular activity, menopause is associated with hormonal changes capable of producing manifestations in different tissues. Among the endocrine changes observed during this period, a decrease in estrogen levels stands out, as this hormone participates in maintaining the structure and function of the skin, hair follicles, and genital mucosa. In the skin, estrogen deficiency may lead to reduced collagen production, decreased skin thickness, loss of elasticity, reduced water retention capacity, and impaired wound healing. As a consequence, dryness, laxity, pruritus, and more prominent wrinkles become common. These manifestations result from reduced fibroblast activity, changes in the extracellular matrix, and reduced cutaneous vascularization. In the hair, thinning of hair shafts, reduced hair density, and increased shedding may be identified due to the imbalance between estrogens and androgens. In some women, a pattern of androgenetic alopecia is observed, with or without the appearance of facial hair. In the genital mucosa, reduced estrogenic stimulation leads to epithelial thinning, decreased vascularization, reduced lubrication, and changes in the vaginal microbiota. Collectively termed genitourinary syndrome of menopause, these manifestations may include vaginal dryness, burning, pruritus, dyspareunia, bleeding during sexual intercourse, and urinary symptoms. Thus, given the repercussions for physical, sexual, and emotional well-being, understanding the effects of estrogen deficiency during menopause is relevant. This study aims to analyze the main changes observed in the skin, hair, and genital mucosa during menopause, with an emphasis on the influence of estrogen deficiency. MATERIALS AND METHODS: A descriptive, qualitative narrative review of the literature was conducted to analyze dermatological, hair, and genital changes related to menopause and estrogen deficiency. To identify studies, publications available in the PubMed/MEDLINE, PubMed Central, SciELO, ScienceDirect, and SpringerLink databases were consulted. The searches used the following Portuguese and English descriptors, individually or in combination: “menopause”, “estrogen deficiency”, “skin”, “skin aging”, “hair”, “alopecia”, “genital mucosa”, “genitourinary syndrome of menopause”, “menopause”, “estrogen deficiency”, “skin”, “hair” and “genitourinary syndrome of menopause”. Original articles, literature reviews, systematic reviews, and guidelines addressing the effects of reduced estrogen on the skin, hair, or genital mucosa of menopausal women were considered eligible. Studies not directly related to the topic, duplicate publications, studies without access to the necessary content, and research focused exclusively on other clinical conditions were excluded. After the titles and abstracts were read, publications considered relevant were selected. Subsequently, through full-text reading, information was extracted regarding pathophysiological mechanisms, clinical manifestations, impact on quality of life, and management options. Finally, the findings were organized in a narrative and integrated manner. RESULTS AND DISCUSSION: Menopause is associated with progressive skin changes related to declining estrogen, including reduced skin collagen and skin thickness. A decline in skin elasticity, increased distensibility and viscosity, reduced sebum production, and a higher prevalence of xerosis, dermatitis, and pruritus, as well as delayed wound healing, were also found. Dermal estrogen receptor-β expression was also found to decline by approximately 15% after menopause, impairing hydration, collagen synthesis, antioxidant defense, cutaneous vascularization, and tissue repair. Regarding effects on hair, topical estrogen showed limited benefits and inferior performance compared with minoxidil, with insufficient evidence to recommend its routine use in the treatment of hair loss, in addition to a possible association with frontal fibrosing alopecia. In the genital mucosa, epithelial thinning, loss of elasticity and vaginal rugae, vaginal shortening, and increased pH were observed, clinically manifesting as vaginal dryness, dyspareunia, dysuria, and recurrent urinary tract infections, a presentation consistent with genitourinary syndrome of menopause, for which local vaginal estrogen therapy demonstrated efficacy and safety. Regarding systemic and topical hormone therapy, the findings indicate increased elasticity, collagen content, skin thickness, and hydration, with a reduced likelihood of dry skin and wrinkles, although larger studies did not confirm significant improvement in wrinkles after four years, reinforcing the need for more evidence before indications exclusively for aesthetic or hair-related purposes. CONCLUSIONS: Menopausal hypoestrogenism compromises skin homeostasis, leading to collagen loss, thinning, reduced elasticity, and impaired barrier function, as well as hair changes and genitourinary syndrome of menopause. Systemic or topical estrogen therapy partially reverses some of these parameters, but the skin and hair benefits are limited and do not, on their own, justify its indication, given the systemic risk profile involved. The available evidence, largely derived from narrative reviews and studies with small samples, reinforces the need for larger and methodologically standardized studies to support individualized preventive and therapeutic strategies.